The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCppgroup Regulatory News (CPP)

Share Price Information for Cppgroup (CPP)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 179.50
Bid: 174.00
Ask: 185.00
Change: 0.00 (0.00%)
Spread: 11.00 (6.322%)
Open: 179.50
High: 0.00
Low: 0.00
Prev. Close: 179.50
CPP Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Globiva Divestment

27 Nov 2023 07:00

RNS Number : 6728U
CPPGroup Plc
27 November 2023
 

27 November 2023

CPPGroup Plc

("the Group"; or "the Company")

 

Globiva Divestment

 

CPP Group (AIM: CPP), a provider of real-time assistance products and resolution services which reduce disruptions to everyday life for millions of customers across the world, has entered into an agreement (the "Agreement") with the founders of Globiva Services Private Ltd ("Globiva") for the disposal of the Group's majority interest in Globiva for an aggregate consideration of approximately £5.1 million1 (the "Transaction"). Globiva is non-core to the Group following the announcement of its revised strategy and Change Management Programme ("CMP") in October 2022 to transform the Group to an InsurTech business, led by Blink Parametric ("Blink").

 

Background

The Group holds a 51% majority interest in Globiva, a Business Processes Management company incorporated in India, with the other 49% of the shares beneficially owned by the three founders of Globiva, Navneet Gupta, Vikram Singh Nathawat, and Ashish Goyal, who continue to manage the business (the "Globiva Founders").

 

Under amended arrangements entered into on 20 July 2022, the Globiva Founders had the option to buy back 10% of the ordinary shares in Globiva, from the Group, for a pre-agreed price of approximately £0.9 million. This was subject to Globiva meeting certain performance targets, which it is on track to achieve. However, in the normal course of business, it was further agreed that this could not be triggered until 1 January 2026 at the earliest. This Agreement supersedes the previous arrangements.

 

Transaction Rationale

· The Transaction is consistent with the Group's stated strategy to transform the Group to an InsurTech business led by Blink and supported by India and Turkey.

· The Group is currently a "trapped" investor in Globiva with limited options to realise value. In addition, the Group was likely to become a minority shareholder (January 2026) and consequently would have lost majority voting rights on key strategic decisions. The Transaction provides an exit path for the Group at an acceptable return.

· The Transaction provides cash flow, not previously forecast, over a three-year period to support the Group's CMP.

 

Transaction Structure

· The sale and transfer of ownership will be conducted over a three-year period concluding in Q1 2027.

· The total aggregate consideration of approximately £5.1 million1 (515 million Indian rupees) represents a blended 7.1x multiple on forecast EBITDA for the 2023, 2024 and 2025 calendar years. Final consideration will be based on audited EBITDA and subject to a maximum adjustment of plus or minus ten percent.

· The Group's shareholding in Globiva, currently 51%, will reduce to approximately 35% in Q1 2025; 13% in Q1 2026; and zero percent in Q1 2027.

· Cash, subject to any EBITDA performance adjustment (noted above) will be received by the Group as follows: approximately £1.2 million in 2024; £1.3 million in 2025; £1.2 million in 2026; and £1.4 million in 2027.

 

For the 2022 financial year, Globiva contributed EBITDA of £2.4 million to the Group's overall EBITDA from continuing operations of £6.9 million, albeit the Group's shareholders only ultimately benefit from 51% of Globiva's results. As at 30 June 2023, Globiva had net assets of £3.6 million.

The Transaction constitutes a related party transaction, pursuant to Rule 13 of the AIM Rules for Companies, as the Globiva Founders are Directors of Globiva. The Group's Directors consider, having consulted with the Company's nominated adviser, Liberum Capital Limited, that the terms of the Transaction are fair and reasonable insofar as the Company's shareholders are concerned.

 

Simon Pyper, Group CEO, commented:

"The agreement we have reached with Globiva is consistent with our stated strategy and provides a positive outcome for both parties. This is another forward step as we simplify the Group and transform to an InsurTech business."

 

1 Approximate, as subject to currency exchange movements.

 

The information contained within this announcement is deemed by the Company to constitute inside information as stipulated under the Market Abuse Regulation (EU) No. 596/2014 as amended by The Market Abuse (Amendment) (EU Exit) Regulations 2019. Upon the publication of this announcement via the Regulatory Information Service, this inside information is now considered to be in the public domain.

 

Enquiries:

 

CPP Group plc

Simon Pyper, Chief Executive Officer Tel: +44 (0)7917 795601

David Bowling, Chief Financial Officer

 

 

Liberum Capital Limited

(Nominated Adviser and Sole Broker) Tel: +44 (0)20 3100 2000

Richard Lindley

Lauren Kettle

 

About CPP Group:

CPP Group is a technology-driven assistance company that creates embedded and ancillary real-time assistance products and resolution services that reduce disruption to everyday life for millions of people across the world, at the time and place they are needed, CPP Group is listed on AIM, operated by the London Stock Exchange.

 

For more information on CPP visit https://corporate.cppgroup.com/

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
AGRBFBLTMTTTBLJ
Date   Source Headline
5th Dec 20172:48 pmRNSTotal Voting Rights
2nd Nov 20174:15 pmRNSDirector/PDMR Shareholding
2nd Nov 20179:45 amRNSHolding(s) in Company
2nd Nov 20179:17 amRNSDirector/PDMR Shareholding
30th Oct 20174:45 pmRNSChange of Registered Office
27th Oct 201711:45 amRNSDirector/PDMR Shareholding
25th Oct 201712:20 pmRNSDirector/PDMR Shareholding
24th Aug 20177:00 amRNSHalf-year Report
11th Aug 20172:14 pmRNSBlock listing Interim Review
1st Aug 201712:50 pmRNSDirectorate Change
27th Jun 201710:15 amRNSStatement re Card Protection Plan Limited
21st Jun 201710:00 amRNSBlock listing Interim Review
20th Jun 20172:18 pmRNSAdditional Listing
19th May 20173:01 pmRNSResult of AGM
16th May 201710:30 amRNSStatement re Homecare Insurance Limited
21st Apr 20172:28 pmRNSDirector/PDMR Shareholding
19th Apr 20177:00 amRNSDirectorate Change
18th Apr 201710:08 amRNSDirector/PDMR Shareholding
13th Apr 20179:00 amRNSNotice of AGM
12th Apr 20174:43 pmRNSDirector/PDMR Shareholding
29th Mar 20175:57 pmRNSHolding(s) in Company
29th Mar 20175:27 pmRNSDirector/PDMR Shareholding
24th Mar 20177:00 amRNSDirectorate Change
24th Mar 20177:00 amRNSAnnual Financial Report
17th Mar 20177:00 amRNSAcquisition
13th Feb 201712:08 pmRNSBlock listing Interim Review
30th Jan 20174:41 pmRNSSecond Price Monitoring Extn
30th Jan 20174:37 pmRNSPrice Monitoring Extension
17th Jan 201712:05 pmRNSPrice Monitoring Extension
30th Dec 20163:33 pmRNSStatement re IT Platform
23rd Dec 20162:23 pmRNSHolding(s) in Company
16th Dec 20169:41 amRNSBlock listing Interim Review
8th Dec 20164:41 pmRNSSecond Price Monitoring Extn
8th Dec 20164:37 pmRNSPrice Monitoring Extension
7th Dec 20164:36 pmRNSPrice Monitoring Extension
18th Nov 20167:00 amRNSTrading Statement
14th Sep 20165:16 pmRNSStatement re IT Platform
18th Aug 20167:00 amRNSHalf-year Report
15th Aug 201611:40 amRNSBlock listing Interim Review
26th Jul 20166:19 pmRNSDirectorate Change
6th Jul 20164:00 pmRNSHolding(s) in Company
5th Jul 20169:15 amRNSTotal Voting Rights
21st Jun 201612:44 pmRNSAdditional Listing
17th Jun 20169:53 amRNSBlock listing Interim Review
19th May 20167:00 amRNSDirectorate Change
18th May 20164:50 pmRNSResult of AGM
18th May 20167:00 amRNSChange of Adviser
16th May 20165:23 pmRNSAGM Statement
16th May 20167:00 amRNSDirectorate Change
9th May 20163:19 pmRNSAGM Statement

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.